文献速递脑血管病神经重症与神经感染

急性缺血性卒中血管内治疗后轻度低温:一项先导随机对照试验

Mild Hypothermia After Endovascular Treatment for Acute Ischemic Stroke: A Pilot Randomized Controlled Trial.
PubMed 文献 · Stroke · 2025-08-12

结果显示目标温度在低温组全部达标并维持,3个月死亡率5%对0%(P=1),mRS 0-2分70%对65%(P=0.736),不良事件以心动过缓和横纹肌溶解较多但可控,提示该方案安全可行,疗效尚需进一步研究。

要点

  • 发病8小时内血管内治疗成功再通的急性缺血性卒中患者,35°C持续48小时轻度低温安全可行。
  • 低温组目标温度全部按方案达到并维持,提示操作可行性良好。
  • 3个月mRS 0-2分及死亡率两组差异无统计学意义,疗效需进一步验证。

核心结论

  • 血管内治疗成功再通后实施35°C持续48小时轻度低温是安全可行的,但部分不良事件(心动过缓、横纹肌溶解)在低温组更常见且可控。
  • 该先导研究显示轻度低温在该人群耐受良好,其有效性尚需进一步研究确认。

研究设计与样本

  • 主要目标为评估可行性与安全性(方案依从性、目标温度的达到与维持、干预相关不良事件)。

主要发现

  • 低温组全部患者按干预方案成功达到并维持目标温度。
  • 3个月死亡率低温组5%、对照组0%(P=1);mRS 0-2分低温组70%、对照组65%(P=0.736)。
  • 心动过缓与横纹肌溶解等不良事件在低温组更常见,但可控。

关键数值与推荐

  • 轻度低温方案:目标温度35°C,持续48小时。
  • 探索性疗效指标:3个月mRS 0-2分;出院时NIHSS评分较基线下降≥4分。
  • 探索性安全性指标:死亡、出血转化及任何出血。

临床怎么用

  • 对发病8小时内血管内治疗成功再通的急性缺血性卒中患者,可考虑35°C持续48小时轻度低温,但需监测心动过缓与横纹肌溶解等不良事件。
  • 该方案目前定位为先导研究,尚不能作为常规治疗推荐,疗效需进一步随机对照研究验证。

局限性

  • 研究仅纳入成功再通且发病8小时内的患者,结果外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Therapeutic hypothermia is a potent neuroprotective therapy that mitigates ischemic brain injury. This study aimed to investigate the safety and feasibility of mild therapeutic hypothermia after successful endovascular recanalization in patients with acute ischemic stroke due to major vessel occlusion. METHODS: We conducted a prospective, multicenter, open-label pilot randomized clinical trial at 5 stroke centers in South Korea between December 2016 and November 2019. Patients with acute ischemic stroke who achieved successful recanalization within 8 hours of symptom onset were included. The participants were randomly assigned in a 1:1 ratio to receive either mild therapeutic hypothermia, targeted at 35 °C for 48 hours, or standard care. The primary objective was to assess feasibility and safety outcomes, including protocol adherence, achievement and maintenance of the target temperature, and adverse events related to the intervention. Exploratory efficacy outcomes included a modified Rankin Scale score of 0 to 2 at 3 months and neurological improvement (≥4-point reduction on the National Institutes of Health Stroke Scale score at discharge). Exploratory safety outcomes included mortality, hemorrhagic transformation, and any bleeding. RESULTS: Forty patients were enrolled in this study, with 20 patients in each group. The target temperature was successfully achieved and maintained in all patients of the mild hypothermia group in accordance with the intervention protocol. At 3 months, the mortality rates were 5% in the mild hypothermia group and 0% in the control group (P=1). A modified Rankin Scale score of 0 to 2 was achieved in 70% and 65% of the mild hypothermia and control groups, respectively (P=0.736). Few adverse events (bradycardia and rhabdomyolysis) were more frequent in the mild hypothermia group but were manageable. CONCLUSIONS: Mild hypothermia at 35 °C after successful recanalization via endovascular treatment in acute ischemic stroke is safe and feasible, despite some adverse events. This pilot study demonstrated that mild hypothermia is well tolerated in this patient population, and further study is needed to confirm its effectiveness. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02985060.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jeong JH, Hong JH, Sohn SI, et al. Mild Hypothermia After Endovascular Treatment for Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Stroke. 2025. PMID: 40791183. doi:10.1161/STROKEAHA.124.049762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。